188 related articles for article (PubMed ID: 12056548)
1. Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form.
Deraët M; Rihakova L; Boucard A; Pèrodin J; Sauvé S; Mathieu AP; Guillemette G; Leduc R; Lavigne P; Escher E
Can J Physiol Pharmacol; 2002 May; 80(5):418-25. PubMed ID: 12056548
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition.
Miura S; Karnik SS
J Hypertens; 1999 Mar; 17(3):397-404. PubMed ID: 10100078
[TBL] [Abstract][Full Text] [Related]
3. Chimeric AT1/AT2 receptors reveal functional similarities despite key amino acid dissimilarities in the domains mediating agonist-dependent activation.
Hines J; Fluharty SJ; Yee DK
Biochemistry; 2001 Sep; 40(37):11251-60. PubMed ID: 11551225
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms.
Ouali R; Berthelon MC; Bégeot M; Saez JM
Endocrinology; 1997 Feb; 138(2):725-33. PubMed ID: 9003008
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the angiotensin type 2 receptor: contribution of conserved amino acids in the region of the sixth transmembrane domain.
Heerding JN; Yee DK; Krichavsky MZ; Fluharty SJ
Regul Pept; 1998 Jun; 74(2-3):113-9. PubMed ID: 9712171
[TBL] [Abstract][Full Text] [Related]
6. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.
Laporte SA; Boucard AA; Servant G; Guillemette G; Leduc R; Escher E
Mol Endocrinol; 1999 Apr; 13(4):578-86. PubMed ID: 10194764
[TBL] [Abstract][Full Text] [Related]
7. Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor.
Yee DK; Kisley LR; Heerding JN; Fluharty SJ
Brain Res Mol Brain Res; 1997 Nov; 51(1-2):238-41. PubMed ID: 9427526
[TBL] [Abstract][Full Text] [Related]
8. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
Turner CA; Cooper S; Pulakat L
Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the angiotensin II type 2 receptor: contribution of conserved extracellular amino acids.
Heerding JN; Yee DK; Jacobs SL; Fluharty SJ
Regul Pept; 1997 Oct; 72(2-3):97-103. PubMed ID: 9652982
[TBL] [Abstract][Full Text] [Related]
10. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction.
Rihakova L; Deraët M; Auger-Messier M; Pérodin J; Boucard AA; Guillemette G; Leduc R; Lavigne P; Escher E
J Recept Signal Transduct Res; 2002; 22(1-4):297-313. PubMed ID: 12503623
[TBL] [Abstract][Full Text] [Related]
11. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure.
Boucard AA; Wilkes BC; Laporte SA; Escher E; Guillemette G; Leduc R
Biochemistry; 2000 Aug; 39(32):9662-70. PubMed ID: 10933782
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of angiotensin II receptor internalization.
Hunyady L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S47-56. PubMed ID: 9892140
[TBL] [Abstract][Full Text] [Related]
13. Identification of angiotensin II type 2 (AT2) receptor domains mediating high-affinity CGP 42112A binding and receptor activation.
Hines J; Heerding JN; Fluharty SJ; Yee DK
J Pharmacol Exp Ther; 2001 Aug; 298(2):665-73. PubMed ID: 11454929
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors.
Servant G; Escher E; Guillemette G
Regul Pept; 1998 Jan; 73(1):35-41. PubMed ID: 9537671
[TBL] [Abstract][Full Text] [Related]
15. Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs.
Servant G; Laporte SA; Leduc R; Escher E; Guillemette G
J Biol Chem; 1997 Mar; 272(13):8653-9. PubMed ID: 9079697
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of angiotensin II (AT1A) receptor endocytosis.
Thomas WG; Thekkumkara TJ; Baker KM
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S74-80. PubMed ID: 8993843
[TBL] [Abstract][Full Text] [Related]
17. Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors.
Prokop JW; Santos RA; Milsted A
PLoS One; 2013; 8(6):e65307. PubMed ID: 23755216
[TBL] [Abstract][Full Text] [Related]
18. Intracellular third loops in AT1 and AT2 receptors determine subtype specificity.
Daviet L; Lehtonen JY; Hayashida W; Dzau VJ; Horiuchi M
Life Sci; 2001 Jun; 69(5):509-16. PubMed ID: 11510946
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptors.
Ardaillou R
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S30-9. PubMed ID: 9892138
[TBL] [Abstract][Full Text] [Related]
20. Intracrine action of angiotensin II in mesangial cells: subcellular distribution of angiotensin II receptor subtypes AT
da Silva Novaes A; Ribeiro RS; Pereira LG; Borges FT; Boim MA
Mol Cell Biochem; 2018 Nov; 448(1-2):265-274. PubMed ID: 29455433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
